Literature DB >> 33977732

Cerebral venous sinus thrombosis and subdural hematoma in a female patient with systemic lupus erythematosus: a case report and literature review.

Jiaai Li1, Hongmei Meng1, Wei Jiang1, Jiaxin Liu2, Zhitao Cui3, Jing Miao1.   

Abstract

Cerebral venous sinus thrombosis (CVST) and subdural hematoma (SDH) are extremely rare in patients with systemic lupus erythematosus (SLE), and when conditions are severe, it can endanger the life of the patients. We report a case of a 44-year-old woman who was admitted to our hospital due to multiple paroxysmal headaches, dizziness, and seizures for 20 days. In the past 2 years, she had severe thrombocytopenia. Her brain computed tomography (CT) and magnetic resonance venography (MRV) demonstrated CVST and a SDH near the right parietal occipital lobe and left temporal parietal lobe. After admission, she was eventually diagnosed with SLE based on the seizures, thrombocytopenia, positive antinuclear antibodies, and anti-ds DNA antibodies. After treatment, the patient's headaches and symptoms completely disappeared, and the myodynamia of the left limbs improved to grade 4. Her platelet count rose to 199×109/L. The second brain MRV and MRI demonstrated partial reopening of the right superior sagittal sinus, transverse sinus, and sigmoid sinus, and the improvement of bilaterally SDH, which revealed that the treatment with an anticoagulant, pulse methylprednisolone therapy, and intravenous gamma globulin was effective. We summarized possible mechanisms in this case, which can improve our understanding of CVST and SDH in SLE. And we consider that such patients should be treated as soon as possible, and the outcome can be good.

Entities:  

Keywords:  Central venous sinus thrombosis (CVST); pulse methylprednisolone therapy; subdural hematoma (SDH); systematic lupus erythematosus (SLE)

Year:  2021        PMID: 33977732     DOI: 10.21037/apm-20-2285

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  1 in total

1.  Clinical Efficacy of Gandakang Tablets plus Methylprednisolone in Patients with Systemic Lupus Erythematosus.

Authors:  Min Wang; Guoquan Li; Shanzhi Wang; Feng Ye; Yanni Huang; Huanan Wang; Feng Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-28       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.